Global Challenges

Health

Kim E. Andreassen

Within the medical disciplines, the University of Bergen has a special focus on issues that are of particular importance to the world's poor. Important topics include childhood and maternal health, infectious diseases, non-communicable diseases (asthma, allergy, mental health, cancer), vaccine development, nutrition, dental health, preventive health care, health promotion, health economics and health systems studies.

Updated: 19.12.2018 (First published: 16.10.2017)

Global challenges

Migration

Health

Inequality

The robot Pepper supports patients at Japanese Nursing Homes.

Handling elder boom with robots

Japan´s elderly people constitute a growing proportion of the population. Norway will face this same situation within 20 years. As Japan is solving the challenge by increasing the use of robots, Norway is tending to focus on conversation and personal contact, says Professor Bettina S. Husebø at SEFAS.

Too expensive bringing newborns to hospital

The poorest families in Ethiopia cannot afford to bring their newborns to hospital, before it is too late. According to researcher Kristine Husøy Onarheim, free healthcare is the solution.

– Migrants are healthier than Norwegians

According to researcher and doctor, Esperanza Diaz, Migrants are healthier than Norwegians in general. Norwegians may have something to learn from the migrants´ lifestyle.

Strengthening health priority in Ethiopia with Gates-Millions

A grant of 3 million US dollars from the Bill & Melinda Gates Foundation is enabling Professor Ole Frithjof Norheim and his research group to teach health priorities to Ethiopian students.

Doctors need Cultural Training

A UiB-study shows that general practioners in Norway show little competency in understanding different cultures. Associate Professor Esperanza Diaz asks for mandatory training.

Asthma Medicine Halves Risk of Parkinson´s

Using data gathered from 100 million Norwegian prescriptions, researchers at the University of Bergen have found that asthma medicine can halve a patient’s risk of developing Parkinson´s disease.